REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 119 filers reported holding REGENXBIO INC in Q1 2018. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $200,446 | -32.5% | 10,600 | -19.1% | 0.00% | 0.0% |
| Q4 2022 | $297,108 | -47.5% | 13,100 | -38.8% | 0.00% | -50.0% |
| Q3 2022 | $566,000 | +32.6% | 21,400 | +23.7% | 0.00% | +100.0% |
| Q2 2022 | $427,000 | -2.5% | 17,300 | +31.1% | 0.00% | 0.0% |
| Q1 2022 | $438,000 | -80.3% | 13,200 | -75.1% | 0.00% | -83.3% |
| Q3 2021 | $2,222,000 | +364.9% | 53,000 | +330.9% | 0.01% | +500.0% |
| Q2 2021 | $478,000 | -64.8% | 12,300 | -69.1% | 0.00% | -75.0% |
| Q1 2021 | $1,358,000 | -26.4% | 39,800 | +10.9% | 0.00% | -20.0% |
| Q2 2019 | $1,844,000 | -64.1% | 35,900 | -60.0% | 0.01% | -61.5% |
| Q1 2019 | $5,141,000 | -10.2% | 89,700 | -34.3% | 0.01% | -18.8% |
| Q4 2018 | $5,726,000 | -43.3% | 136,500 | +2.1% | 0.02% | -36.0% |
| Q3 2018 | $10,094,000 | +1292.3% | 133,700 | +1223.8% | 0.02% | +1150.0% |
| Q2 2018 | $725,000 | +31.3% | 10,100 | -45.4% | 0.00% | +100.0% |
| Q1 2018 | $552,000 | -24.8% | 18,500 | -16.2% | 0.00% | -50.0% |
| Q4 2017 | $734,000 | – | 22,076 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |